NINorihiko Ikeda

Norihiko Ikeda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Norihiko Ikeda has a total of 349 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Personalized Prediction of Postoperative Recurrence in Lung Squamous Cell Carcinoma: Integrating AI-Based Nuclear Morphometry and Clinical Data

    by Tomokazu Omori, Akira Saito, Yoshihisa Shimada, Yujin Kudo, Jun Matsubayashi, Toshitaka Nagao, Masahiko Kuroda, Norihiko Ikeda

    Background: This study employed artificial intelligence (AI) to analyze quantitative nuclear morphological features obtained from digital pathology images to predict postoperative recurrence in patients with lung squamous cell carcinoma (LSQCC). We aimed to develop a prediction model that contributes to the realization of ‘personalized postoperative management’ tailored to individual tumor biology by integrating AI-extracted morphological features with clinical information. Methods: A total of 185 of the 253 surgically resected LSQCC cases were included; 136 were randomly assigned to the training set and 49 to the test set. Nuclear features from manually selected regions of interest were extracted and used to build AI-based prediction models. Three recurrence models were developed: recurrence within 2 years, within 5 years, and a three-category model (≤2 years, 3–5 years, >5 years or no recurrence). Support vector machine (SVM) and random forest (RF) algorithms were applied to each, yielding six predictive models. An ensemble approach was used to calculate AI-based risk scores, and a “total risk score” was developed by integrating these with the pathologic stage. Results: All six AI models demonstrated stable predictive performance, with AUC values ranging from 0.76 to 0.91. Kaplan–Meier analysis showed that the total risk score provided the most precise risk stratification (p < 0.005), with clearer separation between risk groups than the AI-based risk score alone. Conclusions: The integration of AI-based nuclear morphology analysis and clinical data provides an objective and practical tool for personalized postoperative management in LSQCC. This approach enables tailored clinical decision-making by identifying patients at high risk for early recurrence and customizing postoperative treatment plans to meet the specific needs of each individual.

  • Open Access

    Three‐Dimensional Reconstruction and Extended Reality in Thoracic Surgery: Japanese Expert Recommendations From the Anatomy on the Border Expert Consensus Meeting

    by Yujin Kudo, Daisuke Asano, Satoshi Kobayashi, Kentato Miura, Toshiya Abe, Kenoki Ohuchida, Mingyon Mun, Kimihiro Shimizu, Hisashi Iwata, Keiichi Akahoshi, et al.

    Introduction: Precise spatial understanding of the bronchovascular tree is essential for anatomical lung resection. Three‐dimensional (3D) reconstruction and extended‐reality (XR) technologies have emerged as tools for preoperative planning, navigation, and education. We aimed to assess the current use and efficacy of 3D and XR technologies in thoracic surgery in Japan and develop expert recommendations. Methods: Two clinical survey questions on the usefulness of 3D imaging in thoracic surgery and that of VR, AR, and MR were sent to 125 certified thoracic surgical centers. PubMed searches targeted thoracic 3D and XR studies, including English‐language randomized, prospective, and retrospective studies, systematic reviews, and meta‐analyses. Draft statements were refined at the Anatomy on the Border Expert Consensus Meeting (Japan Society for Endoscopic Surgery 2024). Results: Fifty of the 125 institutions (40%) responded. 3D imaging was used by 96% of the institutions, and 72% used it in all cases. “Very” or “moderately” useful was reported by 94% of the institutions. Main purposes for using 3D imaging were preoperative simulation (84%) and anatomical understanding (86%); 52% of the institutions used 3D imaging for intraoperative reference. For XR, awareness was moderate, but adoption remained limited (8%). Among respondents, 74% rated its usefulness as uncertain, while only a small proportion found it clearly useful for preoperative simulation, intraoperative localization, and education. Literature search showed that 3D‐planning reduces blood loss, operative time, and complications in segmentectomy, whereas XR studies demonstrated improved nodule localization and workflow efficiency. Conclusions: 3D imaging should be the standard for complex thoracic resections, particularly segmentectomy. XR is a promising tool, with broader deployment expected as its usability improves and cost decreases.

  • Open Access

    Prediction of Lymphovascular Invasion in Early–Stage Lung Adenocarcinoma Using Artificial Intelligence–Based Radiomics

    by Yoshihisa Shimada, Kazuharu Harada, Yujin Kudo, Jinho Park, Jun Matsubayashi, Masataka Taguri, Norihiko Ikeda

    Objectives: This study utilized artificial intelligence (AI)–based radiomics analysis of computed tomography (CT) images using a modified U–Net for lung nodule segmentation and convolutional neural network based on VGG–16 to predict lymphovascular invasion (LVI) in stage 0–I lung adenocarcinoma. Additionally, the study investigated whether combining radiomics data with serum microRNA (miR)–30d level as a potential biomarker could enhance predictive performance. Methods: A total of 1265 patients who underwent complete resection between 2008 and 2018 were included. AI–based CT analysis was performed, and logistic regression was applied to predict LVI using 35 imaging features. A risk score (RS) generated from 840 patients in the derivation cohort was used to identify a high–risk group, with validation performed using 425 patients. Additionally, 47 cases with extracellular vesicle (EV)–derived miR–30d level data were analyzed to evaluate the value of the integrated approach. Results: Among all the patients, 467 patients (36.9%) were LVI–positive, and LVI was independently associated with poorer overall survival. The receiver operating characteristic curve for LVI based on the RS yielded an area under the curve of 0.899. For LVI prediction, the sensitivity, specificity, and accuracy were 84.8%, 83.7%, and 83.9%, respectively, in the derivation group, and 82.3%, 79.4%, and 80.5%, respectively, in the validation group. The integrated approach with miR–30d enhanced the predictability of LVI, achieving a sensitivity of 93.3%, specificity of 70.5%, and accuracy of 85.1%. Conclusions: AI–based radiomics demonstrated high effectiveness for predicting LVI, with RSs showing broad clinical applications. The addition of EV–derived miR–30d modestly improved predictability.


  • Open Access

    Transforming the Management of Oligometastatic Non-Small Cell Lung Cancer in the Era of Immunotherapy and Targeted Therapy

    by Yohei Kawaguchi, Satoshi Takahashi, Yoshihisa Shimada, Yujin Kudo, Norihiko Ikeda

    Oligometastatic non-small cell lung cancer (omNSCLC) is increasingly recognized as a clinically actionable subset, characterized by a limited number of metastatic lesions and the potential to benefit from combined systemic and local treatments. Advances in systemic therapy, particularly immune checkpoint inhibitors (ICI) and molecular targeted agents, have led to prolonged disease control in selected patients. Prospective clinical trials have shown that incorporating local therapy into systemic treatment can improve progression-free and overall survival outcomes in carefully selected patients with metastatic disease. Radiotherapy has increasingly become the preferred modality for local consolidation, especially when surgical options are limited or impractical. Key factors influencing treatment selection include biomarker status, the number and distribution of metastases, and the response to the initial systemic therapy. The optimal timing and modality of local interventions remain under investigation. This review examines the evolving treatment strategies for omNSCLC, primarily from the perspective of systemic therapies. By contextualizing local treatment modalities within the framework of immunotherapy and targeted therapy, we reinterpret current evidence to clarify when and how local therapy contributes to long-term disease control.


  • Open Access

    Anatomy on the Border Expert Consensus Meeting: Current Status and Future Perspectives of Three‐Dimensional Image Reconstruction and Immersive Technologies in Liver Surgery

    by Daisuke Asano, Yujin Kudo, Satoshi Kobayashi, Toshiya Abe, Kenoki Ohuchida, Keiichi Akahoshi, Go Wakabayashi, Kimihiro Shimizu, Mingyon Mun, Hisashi Iwata, et al.

    Introduction: The Japan Society for Endoscopic Surgery organized the Anatomy on the Border Expert Consensus Meeting in 2024 to foster cross‐disciplinary discussions. One of the themes, on parenchymal organs, brought together liver, lung, and kidney specialists to jointly discuss the current status and future perspectives of three‐dimensional image reconstruction and augmented/virtual/mixed reality technologies in surgery. This report summarizes the results of these discussions in relation to liver surgery. Methods: A questionnaire was distributed to board‐certified expert training facilities of the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery and liver surgeons certified by the Japan Society for Endoscopic Surgery. A systematic review of English language articles published between 2015 and 2024 was also conducted. Results: Responses were obtained from 86 institutions. The majority (88%) reported routine use of three‐dimensional image reconstruction, mainly for preoperative planning (92%) and anatomical understanding (88%). It was rated as very or moderately useful by 99% of respondents. A literature review confirmed the perioperative benefits of this technique. In contrast, augmented/virtual/mixed reality technologies were used in only 16% of the institutions; the majority of these (79%) acknowledged their usefulness, primarily for anatomical understanding and education. The barriers to implementation included cost and data preparation complexity. The educational benefits were supported by data from randomized controlled trials; however, clinical evidence remains limited and inconsistent. Conclusion: Three‐dimensional image reconstruction has become essential in liver surgery. Augmented/virtual/mixed reality technologies, although in the early stages, show promise for surgical education and may eventually contribute to surgical practice as accessibility improves.

  • Open Access

    Clinical Practice and Survey of Three‐Dimensional Images, Virtual Reality, Augmented Reality and Mixed Reality for Robotic‐Assisted Surgery in Urology—“Anatomy on the Border” Expert Consensus Meeting

    by Satoshi Kobayashi, Daisuke Asano, Yujin Kudo, Shintaro Narita, Shuichi Morizane, Toshiya Abe, Kenoki Ohuchida, Tomonori Habuchi, Atsushi Takenaka, Go Wakabayashi, et al.

    Background and Objectives: There have been no nationwide surveys on the effectiveness of 3D images, virtual reality (VR), augmented reality (AR), and mixed reality (MR) in robotic‐assisted surgery for urology. This study aimed to conduct a nationwide survey of techniques for laparoscopic and robotic 3D images, VR, AR, and MR in urology, and to propose a consensus on their effectiveness. Material and Methods: In July 2024, the Japan Society for Endoscopic Surgery conducted an anonymous online survey to evaluate the effectiveness of 3D images, VR, AR, and MR among 44 certified laparoscopic technicians and qualified proctors in robotic surgery. Results: Thirty‐two urologists surveyed reported using 3D imaging for preoperative evaluation (84%) and to understand anatomy (75%), with 97% reporting clinical benefits and 85% indicating that it improved the quality of surgery. This widespread usage and the reported benefits of 3D imaging in urology should reassure the audience about the effectiveness of this technology. VR/AR/MR were primarily used for simulation (19%) and navigation (16%). While 63% expressed interest in these technologies, 51% reported never having used them. Among the barriers to adoption, 25% cited high cost, 24% cited the effort required for data processing, and 14% cited the difficulty of use. Conclusion: 3D images and VR/AR/MR technologies were expected to play a pivotal role in urological robotic surgery. These technologies have the potential to enhance precision and improve outcomes significantly. This study provided a comprehensive overview of the current usage status and challenges associated with these techniques.


  • Open Access

    Impact of COVID-19 on hospital visit behaviour in cancer patients in Japan: a nationwide study

    by Ryo Seishima, Hisateru Tachimori, Kazumasa Fukuda, Norihiko Ikeda, Hiroaki Miyata, Kiyohide Fushimi, Yuko Kitagawa

    Objectives Lockdowns and outing restrictions during the COVID-19 pandemic may have altered attitudes towards hospital visits. This study aimed to investigate changes in long-distance visits outside of secondary healthcare service areas (SHSA) among cancer patients in Japan. Design Retrospective observational study. Setting Inpatient data from the Japanese Diagnosis Procedure Combination database. Primary and secondary outcome measures We retrospectively analysed inpatient data from January 2018 to December 2021, extracted from the Japanese Diagnosis Procedure Combination database. The study examined whether the patient’s hospital was within their residence’s SHSA and compared the admission rates before and after the pandemic. Results The data of a total of 2 394 760 patients were analysed. Admission rates outside the SHSA significantly decreased after the pandemic compared with prepandemic years (26.67% and 27.58%, respectively, pConclusions Admission to distant hospitals among cancer patients decreased following the COVID-19 pandemic, indicating a restraint in their behaviour of visiting distant hospitals. The appropriate allocation of specialised hospitals will serve as a measure for the next pandemic.


  • Open Access

    Supplementary Table S2 from Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1–Positive NSCLC: A Phase II Trial (EAST ENERGY)

    by Keiju Aokage, Shohei Koyama, Shogo Kumagai, Kotaro Nomura, Yoshihisa Shimada, Kiyotaka Yoh, Masashi Wakabayashi, Miki Fukutani, Hideki Furuya, Tomohiro Miyoshi, et al.

    Supplementary Table S2: Representativeness of Study Participants.

  • Open Access

    Supplementary Table S5 from Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1–Positive NSCLC: A Phase II Trial (EAST ENERGY)

    by Keiju Aokage, Shohei Koyama, Shogo Kumagai, Kotaro Nomura, Yoshihisa Shimada, Kiyotaka Yoh, Masashi Wakabayashi, Miki Fukutani, Hideki Furuya, Tomohiro Miyoshi, et al.

    Supplementary Table S5: Surgical methods and approaches in patients who underwent surgery.

  • Open Access

    Supplementary Appendix S1 from Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1–Positive NSCLC: A Phase II Trial (EAST ENERGY)

    by Keiju Aokage, Shohei Koyama, Shogo Kumagai, Kotaro Nomura, Yoshihisa Shimada, Kiyotaka Yoh, Masashi Wakabayashi, Miki Fukutani, Hideki Furuya, Tomohiro Miyoshi, et al.

    Supplementary Appendix S1: EAST_ENERGY_Protocol_v7.